Monomer preference of EGFR tyrosine kinase inhibitors...

  • Main
  • 2019 / 06
  • Monomer preference of EGFR tyrosine kinase inhibitors...
Molecular Cancer Therapeutics 2019 / 06

Monomer preference of EGFR tyrosine kinase inhibitors influences the synergistic efficacy of combination therapy with cetuximab

Oashi, Ayano, Yasuda, Hiroyuki, Kobayashi, Keigo, Tani, Tetsuo, Hamamoto, Junko, Masuzawa, Keita, Manabe, Tadashi, Terai, Hideki, Ikemura, Shinnosuke, Kawada, Ichiro, Naoki, Katsuhiko, Soejima, Kenzo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-18-1036
Date:
June, 2019
File:
PDF, 1.92 MB
english, 2019
Conversion to is in progress
Conversion to is failed